PGP and gastric cancer: Recently, Zhao et al. (2015) demonstrated that, in gastric cancer cells, hyperglycemia may confer MDR at least partially by increasing the nicotinamide phosphoribosyltransferase (Nampt) and the silent information regulator 1 (Sirt1) expression, promoting Pgp level and reducing Topo IIα expression.